The Pioglitazone reference article from the English Wikipedia on 24-Apr-2004 (provided by Fixed Reference: snapshots of Wikipedia from wikipedia.org)

Pioglitazone

In medicine and pharmacology, pioglitazone is a member of the drug class of the thiazolidinediones.

It is being marketed as Actos® by the pharmaceutical companies Takeda and Eli Lilly.

Like other thiazolidinediones, its mechanism of action is by activation the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.

Table of contents

1 Side-effects and contraindications 2 See also 3 External links

Side-effects and contraindications

See main article: thiazolidinedione

See also

• Anti-diabetic drugs
• Peroxisome proliferator-activated receptor

External links

• MedlinePlus article on pioglitazone.
• Diabetes monitor on Pioglitazone

This is the "Pioglitazone" reference article from the English Wikipedia. All text is available under the terms of the GNU Free Documentation License. See also our Disclaimer.